Valerio Damiani
Overview
Explore the profile of Valerio Damiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Changes in the pharyngeal and nasal microbiota in pediatric patients with adenotonsillar hypertrophy
Del Chierico F, Piazzesi A, Fiscarelli E, Ristori M, Pirona I, Russo A, et al.
Microbiol Spectr
. 2024 Sep;
12(10):e0072824.
PMID: 39248478
Importance: Adenotonsillar hypertrophy (AH) is considered the main cause of breathing disorders during sleep in children. AH patients, after significant morbidity and often multiple courses of antibiotics, often proceed to...
2.
Tosca M, Varricchio A, Schiavetti I, Naso M, Damiani V, Ciprandi G
Allergol Immunopathol (Madr)
. 2024 May;
52(3):22-30.
PMID: 38721952
Background: Preschoolers frequently have respiratory infections (RIs), which may cause wheezing in some subjects. Type 2 polarization may favor increased susceptibility to RIs and associated wheezing. Non-pharmacological remedies are garnering...
3.
Ciprandi G, Schindler A, Damiani V
Eur J Ophthalmol
. 2024 Jan;
34(3):NP127-NP128.
PMID: 38291663
No abstract available.
4.
Ciprandi G, Bonini S, Schiavetti I, Damiani V
Int J Ophthalmol
. 2023 Oct;
16(10):1616-1622.
PMID: 37854363
Aim: To evaluate the efficacy and tolerability of administering a combined therapy in patients with dry eye syndrome (DES) and associated laryngopharyngeal reflux (LPR). Methods: The study was retrospective, open,...
5.
Damiani V, Ciprandi G
Minerva Gastroenterol (Torino)
. 2023 Aug;
70(4):470-472.
PMID: 37534863
No abstract available.
6.
Passali D, Passali G, Damiani V, Ciprandi G
Eur Arch Otorhinolaryngol
. 2023 Jun;
280(10):4713-4714.
PMID: 37277684
No abstract available.
7.
Ciprandi G, Maria Bellussi L, Damiani V, Passali D
Acta Biomed
. 2021 Nov;
92(S6):e2021455.
PMID: 34739475
The COVID-19 pandemic era is causing a relevant issue for the health. There is no specific drug able to antagonize the SARS-CoV-2 infection. As a consequence, there is growing interest...
8.
Ciprandi G, La Mantia I, Damiani V, Passali D
Expert Rev Clin Immunol
. 2020 Oct;
16(11):1047-1052.
PMID: 33022191
Introduction: Children with recurrent respiratory infections (RRI) represent a social issue for the economic burden and the negative family impact. Local Bacteriotherapy is an attractive therapeutic strategy that could be...
9.
Ciprandi G, Maria Bellussi L, Passali G, Damiani V, Passali D
Expert Rev Clin Immunol
. 2020 Apr;
16(5):457-463.
PMID: 32252560
Introduction: High mobility group protein box 1 (HMGB1) is a protein belonging to the alarmin family. HMGB1 has a relevant role in starting the inflammatory cascade by means of receptors,...
10.
Ciprandi G, Gallo F, Damiani V, Ameli F
Acta Biomed
. 2020 Feb;
91(1-S):77-80.
PMID: 32073566
Tonsil hypertrophy (TH) and adenoid hypertrophy (AH) are very common in children. Adenoid is visible only by endoscopy. This study investigated the possible relationship between the tonsil and adenoid volume...